FI65910C - Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan - Google Patents

Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan Download PDF

Info

Publication number
FI65910C
FI65910C FI773568A FI773568A FI65910C FI 65910 C FI65910 C FI 65910C FI 773568 A FI773568 A FI 773568A FI 773568 A FI773568 A FI 773568A FI 65910 C FI65910 C FI 65910C
Authority
FI
Finland
Prior art keywords
resin
coating
drug
particles
phenylpropanolamine
Prior art date
Application number
FI773568A
Other languages
English (en)
Finnish (fi)
Other versions
FI65910B (fi
FI773568A (fi
Inventor
Yegnaswami Raghunathan
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of FI773568A publication Critical patent/FI773568A/fi
Publication of FI65910B publication Critical patent/FI65910B/fi
Application granted granted Critical
Publication of FI65910C publication Critical patent/FI65910C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI773568A 1976-11-26 1977-11-24 Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan FI65910C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US74532576 1976-11-26
US80010577A 1977-05-24 1977-05-24
US80010577 1977-05-24

Publications (3)

Publication Number Publication Date
FI773568A FI773568A (fi) 1978-05-27
FI65910B FI65910B (fi) 1984-04-30
FI65910C true FI65910C (fi) 1984-08-10

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
FI773568A FI65910C (fi) 1976-11-26 1977-11-24 Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan

Country Status (21)

Country Link
JP (1) JPS609697B2 (de)
AR (1) AR218047A1 (de)
AT (1) AT359197B (de)
AU (1) AU511080B2 (de)
BE (1) BE861141A (de)
CA (1) CA1086226A (de)
CH (1) CH639560A5 (de)
DE (1) DE2752728C2 (de)
DK (1) DK150534C (de)
FI (1) FI65910C (de)
FR (1) FR2373288A1 (de)
GB (1) GB1544761A (de)
GR (1) GR61724B (de)
IE (1) IE45998B1 (de)
IL (1) IL53462A (de)
LU (1) LU78584A1 (de)
NL (1) NL182283C (de)
NO (1) NO147626C (de)
NZ (1) NZ185772A (de)
PT (1) PT67323B (de)
SE (1) SE426781B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
DE69107461T2 (de) * 1990-08-07 1995-06-22 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
AU2018347991A1 (en) 2017-10-09 2020-05-07 Rhodes Pharmaceuticals L.P. Pharmaceutical resinate compositions and methods of making and using thereof
WO2020234842A1 (en) * 2019-05-23 2020-11-26 G.D Societa' Per Azioni Filling unit to fill a container, in particular a cartridge, with a liquid product of the pharmaceutical industry

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (de) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Also Published As

Publication number Publication date
FI65910B (fi) 1984-04-30
DK150534C (da) 1987-10-12
AU511080B2 (en) 1980-07-24
PT67323A (en) 1977-12-01
DE2752728C2 (de) 1985-08-01
FR2373288A1 (fr) 1978-07-07
SE426781B (sv) 1983-02-14
FR2373288B1 (de) 1980-06-13
NL182283B (nl) 1987-09-16
NO147626C (no) 1983-05-25
IL53462A (en) 1980-12-31
JPS609697B2 (ja) 1985-03-12
SE7713370L (sv) 1978-05-27
CA1086226A (en) 1980-09-23
IE45998L (en) 1978-05-26
AU3098677A (en) 1979-05-31
NO774051L (no) 1978-05-29
NZ185772A (en) 1978-12-18
NL7712996A (nl) 1978-05-30
NL182283C (nl) 1988-02-16
JPS5369822A (en) 1978-06-21
DK150534B (da) 1987-03-23
LU78584A1 (de) 1978-04-20
PT67323B (en) 1979-04-24
DE2752728A1 (de) 1978-06-01
AR218047A1 (es) 1980-05-15
FI773568A (fi) 1978-05-27
ATA848077A (de) 1980-03-15
NO147626B (no) 1983-02-07
GR61724B (en) 1978-12-29
DK523277A (da) 1978-05-27
GB1544761A (en) 1979-04-25
AT359197B (de) 1980-10-27
IL53462A0 (en) 1978-01-31
BE861141A (fr) 1978-03-16
CH639560A5 (en) 1983-11-30
IE45998B1 (en) 1983-01-26

Similar Documents

Publication Publication Date Title
US4221778A (en) Prolonged release pharmaceutical preparations
US4847077A (en) Controlled release pharmaceutical preparations
Raghunathan et al. Sustained‐release drug delivery system I: Coated ion‐exchange resin system for phenylpropanolamine and other drugs
FI96273C (fi) Menetelmä lääkettä säännöstellysti vapauttavan annostusmuodon valmistamiseksi
FI87045B (fi) Farmaceutiska baerare, vilka frigoer aktivaemnet reglerbart.
CA2016039C (en) Extended release pharmaceutical formulations
JP6144252B2 (ja) 医薬組成物
US5188841A (en) Sustained release pharmaceutical formulations
US5413782A (en) Binding pharmaceuticals to ion exchange resins
KR920007568B1 (ko) 방출속도가 조절된 약학적 제제의 제조방법
JP2001520187A (ja) 経口モルヒネ多粒子状製剤
FI65910C (fi) Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan
PT642335E (pt) Preparacao de um sal de morfina de libertacao controlada
JPH05279247A (ja) 徐放性液剤
US4859461A (en) Coatable ion exchange resins
EP0519870A1 (de) Neue orale Diclofenaczubereitung
JP2001502671A (ja) ＨＭＧ―ＣｏＡ還元酵素阻害剤フルバスタチンの徐放性医薬組成物
JP2670777B2 (ja) 被覆性イオン交換樹脂
EP0264989A1 (de) Perorale galenische Formulierungen von Rheinderivaten mit verzögerter Freigabe
Zhang et al. Preparation and in vitro in vivo characterization of polyelectrolyte alginate–chitosan complex based microspheres loaded with verapamil hydrochloride for improved oral drug delivery
EP2329813A1 (de) Wässrige Retard-Freisetzungsform für hochwasserlösliche Elektrolytarzneistoffe
AU663695B2 (en) Polyamine drug-resin complexes
CA1283497C (en) Polymer-treated ion exchange resins
Pisal et al. Drug release properties of polyethylene-glycol-treated ciprofloxacin-Indion 234 complexes
Giammona et al. New hydrogel matrices based on chemical crosslinked α, β-polyas parthydrazide: Synthesis, characterization and in vivo biocompatibility studies

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: FISONS CORPORATION